Fropofol prevents disease progression in mice with hypertrophic cardiomyopathy

Abstract

Direct inhibition of myofilament contraction by fropofol prevents HCM disease phenotypic expression and progression, suggesting that increased myofilament contractile force is the primary trigger for hypertrophy development and HCM disease progression.